| scholarly article | Q13442814 |
| P50 | author | Timothy M. Uyeki | Q84362200 |
| P2860 | cites work | Neuraminidase inhibitors for preventing and treating influenza in adults and children | Q24197463 |
| Neuraminidase inhibitors for preventing and treating influenza in children | Q24203875 | ||
| Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982–2012: A Systematic Analysis | Q26751854 | ||
| Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies | Q28260818 | ||
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data. | Q30362392 | ||
| Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza | Q30388177 | ||
| Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015 | Q30396792 | ||
| Influenza antivirals currently in late-phase clinical trial | Q30398099 | ||
| Impact of Outpatient Neuraminidase Inhibitor Treatment in Patients Infected With Influenza A(H1N1)pdm09 at High Risk of Hospitalization: An Individual Participant Data Metaanalysis | Q30398645 | ||
| Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season | Q34354261 | ||
| Neuraminidase inhibitors for influenza | Q34455162 | ||
| Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. | Q34785408 | ||
| Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. | Q35906893 | ||
| Use of influenza antiviral medications among outpatients at high risk for influenza-associated complications during the 2013-2014 influenza season | Q35974465 | ||
| The burden of influenza in young children, 2004-2009. | Q36568801 | ||
| End points for testing influenza antiviral treatments for patients at high risk of severe and life-threatening disease | Q37737726 | ||
| Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis | Q37955413 | ||
| A randomized, double-blind, placebo-controlled trial evaluating the safety of early oseltamivir treatment among children 0-9 years of age hospitalized with influenza in El Salvador and Panama | Q39566483 | ||
| Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015. | Q40069401 | ||
| Efficacy of oseltamivir treatment started within 5 days of symptom onset to reduce influenza illness duration and virus shedding in an urban setting in Bangladesh: a randomised placebo-controlled trial | Q40152886 | ||
| Limited and Variable Use of Antivirals for Children Hospitalized With Influenza | Q40361541 | ||
| Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses. | Q41927918 | ||
| Influenza-associated pediatric deaths in the United States, 2004-2012. | Q42259236 | ||
| Burden of seasonal influenza hospitalization in children, United States, 2003 to 2008. | Q43695395 | ||
| Oral oseltamivir improves pulmonary function and reduces exacerbation frequency for influenza-infected children with asthma. | Q45305818 | ||
| Estimates of global seasonal influenza-associated respiratory mortality: a modelling study | Q46876629 | ||
| Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials | Q47397356 | ||
| Influenza Antiviral Prescribing for Outpatients with an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications during Five Influenza Seasons-United States, 2011-2016. | Q47720310 | ||
| Influenza-Associated Deaths among Children in the United States, 2003–2004 | Q57385012 | ||
| COMMITTEE ON INFECTIOUS DISEASES. Recommendations for Prevention and Control of Influenza in Children, 2017 - 2018. Pediatrics. 2017;140(4):e20172550 | Q89758414 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | oseltamivir | Q211509 |
| P304 | page(s) | 1501-1503 | |
| P577 | publication date | 2018-05-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Oseltamivir Treatment of Influenza in Children | |
| P478 | volume | 66 |
Search more.